Delivery Order SPE2DB22D9239-SPE2DB24FDE83
Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $34K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $34,490.80. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered by November 6, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million, to provide pharmaceuticals and medical supplies through December 2025. As a woman-owned small business, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty thousand thirty-five dollars and eight cents ($50,035.08) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will deliver one hundred twenty (120)...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency's prime vendor contract for pharmaceuticals. The order, valued at one hundred three thousand four hundred seventy-two dollars and forty cents ($103,472.40), is for the supply of one hundred twenty capsules of XTANDI 40 MG CAPSULE to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. The delivery order has a period of performance through...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twelve thousand five hundred eight dollars and seventy-seven cents ($12,508.77) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide sixty tablets of...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide XTANDI 40 MG CAPSULE 120S. The $12,934.05 order has a completion date of December 5, 2023 and was awarded on December 4, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at sixty-four thousand six hundred seventy dollars and twenty-five cents ($64,670.25) by the Defense Logistics Agency Troop Support Medical. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency to supply pharmaceuticals and medical products. The delivery order provides for one hundred twenty capsules of XTANDI forty...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $4,311.35. The delivery order is for 120 capsules of XTANDI 40 MG CAPSULE to fulfill requirements at the Park Ridge, Illinois place of performance by December 4, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency not to exceed $5 million through December 2025 to provide pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $8,622.72 by the Defense Logistics Agency to supply 4562586499 XTANDI 40 MG CAPSULE 120S. The order was awarded on October 24, 2023 and is to be completed by October 25, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business located in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order worth $25,868.10 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for 120 capsules of the pharmaceutical product XTANDI 40 MG and has a completion date of February 7, 2024. This order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025, which enables the DLA to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $4,311.35. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered by November 22, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million, to provide various pharmaceutical and medical supplies through December 2025. This delivery order was issued to...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDE83Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $34,490.80. The order calls for the delivery of 4562939401 XTANDI 40 MG CAPSULE 120S to Park Ridge, Illinois by November 30, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group provides pharmaceuticals and medical supplies in support of military treatment facilities worldwide.
Generated 2/28/24, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 11/29/23 |